Literature DB >> 20089206

Targeted disruption of outer limiting membrane junctional proteins (Crb1 and ZO-1) increases integration of transplanted photoreceptor precursors into the adult wild-type and degenerating retina.

R A Pearson1, A C Barber, E L West, R E MacLaren, Y Duran, J W Bainbridge, J C Sowden, R R Ali.   

Abstract

Diseases culminating in photoreceptor loss are a major cause of untreatable blindness. Transplantation of rod photoreceptors is feasible, provided donor cells are at an appropriate stage of development when transplanted. Nevertheless, the proportion of cells that integrate into the recipient outer nuclear layer (ONL) is low. The outer limiting membrane (OLM), formed by adherens junctions between Müller glia and photoreceptors, may impede transplanted cells from migrating into the recipient ONL. Adaptor proteins such as Crumbs homologue 1 (Crb1) and zona occludins (ZO-1) are essential for localization of the OLM adherens junctions. We investigated whether targeted disruption of these proteins enhances donor cell integration. Transplantation of rod precursors in wild-type mice achieved 949 +/- 141 integrated cells. By contrast, integration is significantly higher when rod precursors are transplanted into Crb1(rd8/rd8) mice, a model of retinitis pigmentosa and Lebers congenital amaurosis that lacks functional CRB1 protein and displays disruption of the OLM (7,819 +/- 1,297; maximum 15,721 cells). We next used small interfering (si)RNA to transiently reduce the expression of ZO-1 and generate a reversible disruption of the OLM. ZO-1 knockdown resulted in similar, significantly improved, integration of transplanted cells in wild-type mice (7,037 +/- 1,293; maximum 11,965 cells). Finally, as the OLM remains largely intact in many retinal disorders, we tested whether transient ZO-1 knockdown increased integration in a model of retinitis pigmentosa, the rho(-/-) mouse; donor cell integration was significantly increased from 313 +/- 58 cells without treatment to 919 +/- 198 cells after ZO-1 knockdown. This study shows that targeted disruption of OLM junctional proteins enhances integration in the wild-type and degenerating retina and may be a useful approach for developing photoreceptor transplantation strategies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20089206      PMCID: PMC2938729          DOI: 10.3727/096368909X486057

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  56 in total

1.  Multiple phosphorylated isoforms of NRL are expressed in rod photoreceptors.

Authors:  P K Swain; D Hicks; A J Mears; I J Apel; J E Smith; S K John; A Hendrickson; A H Milam; A Swaroop
Journal:  J Biol Chem       Date:  2001-07-27       Impact factor: 5.157

2.  Development and degeneration of retina in rds mutant mice: analysis of interphotoreceptor matrix staining in chimaeric retina.

Authors:  S Sanyal; R K Hawkins; G H Zeilmaker
Journal:  Curr Eye Res       Date:  1988-12       Impact factor: 2.424

3.  Pals1/Mpp5 is required for correct localization of Crb1 at the subapical region in polarized Muller glia cells.

Authors:  Agnes G S H van Rossum; Wendy M Aartsen; Jan Meuleman; Jan Klooster; Anna Malysheva; Inge Versteeg; Jean-Pierre Arsanto; André Le Bivic; Jan Wijnholds
Journal:  Hum Mol Genet       Date:  2006-08-02       Impact factor: 6.150

4.  Transplantation of neural progenitor cells into the developing retina of the Brazilian opossum: an in vivo system for studying stem/progenitor cell plasticity.

Authors:  D S Sakaguchi; S J Van Hoffelen; E Theusch; E Parker; J Orasky; M M Harper; A Benediktsson; M J Young
Journal:  Dev Neurosci       Date:  2004       Impact factor: 2.984

5.  Ultrastructure of adult rd mouse retina.

Authors:  Peter Gouras; Teruyo Tanabe
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-04-25       Impact factor: 3.117

6.  Functional delivery of synthetic naked siRNA to the human trabecular meshwork in perfused organ cultures.

Authors:  Nuria Comes; Teresa Borrás
Journal:  Mol Vis       Date:  2007-08-01       Impact factor: 2.367

7.  Novel distribution of junctional adhesion molecule-C in the neural retina and retinal pigment epithelium.

Authors:  Lauren L Daniele; Ralf H Adams; Diane E Durante; Edward N Pugh; Nancy J Philp
Journal:  J Comp Neurol       Date:  2007-11-10       Impact factor: 3.215

8.  Altered expression and interaction of adherens junction proteins in the developing OLM of the Rho(-/-) mouse.

Authors:  Matthew Campbell; Marian Humphries; Paul Kenna; Peter Humphries; Brenda Brankin
Journal:  Exp Eye Res       Date:  2007-08-15       Impact factor: 3.467

Review 9.  Differentiation and morphological integration of neural progenitor cells transplanted into the developing mammalian eye.

Authors:  D S Sakaguchi; S J Van Hoffelen; M J Young
Journal:  Ann N Y Acad Sci       Date:  2003-05       Impact factor: 5.691

10.  Regulation of PCNA and cyclin D1 expression and epithelial morphogenesis by the ZO-1-regulated transcription factor ZONAB/DbpA.

Authors:  Tony Sourisseau; Anastasios Georgiadis; Anna Tsapara; Robin R Ali; Richard Pestell; Karl Matter; Maria S Balda
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

View more
  59 in total

1.  XIAP therapy increases survival of transplanted rod precursors in a degenerating host retina.

Authors:  Jingyu Yao; Kecia L Feathers; Hemant Khanna; Debra Thompson; Catherine Tsilfidis; William W Hauswirth; John R Heckenlively; Anand Swaroop; David N Zacks
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-01       Impact factor: 4.799

2.  Human CRB1-associated retinal degeneration: comparison with the rd8 Crb1-mutant mouse model.

Authors:  Tomas S Aleman; Artur V Cideciyan; Geoffrey K Aguirre; Wei Chieh Huang; Cristina L Mullins; Alejandro J Roman; Alexander Sumaroka; Melani B Olivares; Frank F Tsai; Sharon B Schwartz; Luk H Vandenberghe; Maria P Limberis; Edwin M Stone; Peter Bell; James M Wilson; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-29       Impact factor: 4.799

3.  Comparison of two methods used to culture and purify rat retinal Müller cells.

Authors:  Wei-Tao Song; Xue-Yong Zhang; Si-Qi Xiong; Dan Wen; Jian Jiang; Xiao-Bo Xia
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

4.  From embryonic stem cells to mature photoreceptors.

Authors:  David M Gamm; Lynda S Wright
Journal:  Nat Biotechnol       Date:  2013-08       Impact factor: 54.908

5.  Chapter 4 - Restoring Vision to the Blind: Stem Cells and Transplantation.

Authors: 
Journal:  Transl Vis Sci Technol       Date:  2014-12-30       Impact factor: 3.283

6.  Continuous non-cell autonomous reprogramming to generate retinal ganglion cells for glaucomatous neuropathy.

Authors:  Sowmya Parameswaran; Shashank Manohar Dravid; Pooja Teotia; Raghu R Krishnamoorthy; Fang Qiu; Carol Toris; John Morrison; Iqbal Ahmad
Journal:  Stem Cells       Date:  2015-06       Impact factor: 6.277

7.  Adequate Time Window and Environmental Factors Supporting Retinal Graft Cell Survival in rd Mice.

Authors:  Michiko Mandai; Kohei Homma; Satoshi Okamoto; Chikako Yamada; Akane Nomori; Masayo Takahashi
Journal:  Cell Med       Date:  2012-04-20

Review 8.  Translating induced pluripotent stem cells from bench to bedside: application to retinal diseases.

Authors:  Alona O Cramer; Robert E MacLaren
Journal:  Curr Gene Ther       Date:  2013-04       Impact factor: 4.391

9.  Characterization of Three-Dimensional Retinal Tissue Derived from Human Embryonic Stem Cells in Adherent Monolayer Cultures.

Authors:  Ratnesh K Singh; Ramya K Mallela; Pamela K Cornuet; Aaron N Reifler; Andrew P Chervenak; Michael D West; Kwoon Y Wong; Igor O Nasonkin
Journal:  Stem Cells Dev       Date:  2015-09-10       Impact factor: 3.272

10.  Cone and rod photoreceptor transplantation in models of the childhood retinopathy Leber congenital amaurosis using flow-sorted Crx-positive donor cells.

Authors:  J Lakowski; M Baron; J Bainbridge; A C Barber; R A Pearson; R R Ali; J C Sowden
Journal:  Hum Mol Genet       Date:  2010-09-21       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.